Loading...
XNAS
SHC
Market cap3.35bUSD
Jul 11, Last price  
11.80USD
1D
-0.76%
1Q
12.27%
IPO
-57.78%
Name

Sotera Health Co

Chart & Performance

D1W1MN
P/E
75.44
P/S
3.04
EPS
0.16
Div Yield, %
Shrs. gr., 5y
0.03%
Rev. gr., 5y
7.17%
Revenues
1.10b
+4.88%
746,149,000778,327,000818,158,000931,478,0001,003,687,0001,049,288,0001,100,441,000
Net income
44m
-13.58%
-5,870,000-20,425,000-37,491,000116,882,000-233,570,00051,376,00044,398,000
CFO
224m
P
119,563,000149,041,000120,585,000281,545,000277,961,000-147,732,000224,164,000
Earnings
Aug 04, 2025

Profile

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
IPO date
Nov 20, 2020
Employees
3,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
1,100,441
4.88%
1,049,288
4.54%
1,003,687
7.75%
Cost of revenue
498,146
472,130
446,683
Unusual Expense (Income)
NOPBT
602,295
577,158
557,004
NOPBT Margin
54.73%
55.00%
55.50%
Operating Taxes
69,476
54,651
(9,541)
Tax Rate
11.54%
9.47%
NOPAT
532,819
522,507
566,545
Net income
44,398
-13.58%
51,376
-122.00%
(233,570)
-299.83%
Dividends
Dividend yield
Proceeds from repurchase of equity
(4,428)
(4,089)
(393)
BB yield
0.11%
0.09%
0.02%
Debt
Debt current
22,782
34,207
206,395
Long-term debt
2,455,581
2,406,139
1,834,923
Deferred revenue
18,762
18,902
Other long-term liabilities
147,884
65,262
141,859
Net debt
2,201,121
2,129,157
1,610,260
Cash flow
Cash from operating activities
224,164
(147,732)
277,961
CAPEX
(179,070)
(214,975)
(182,378)
Cash from investing activities
(178,996)
(214,906)
(181,896)
Cash from financing activities
(50,564)
265,959
197,761
FCF
414,486
289,271
544,605
Balance
Cash
277,242
301,654
396,294
Long term investments
9,535
34,764
Excess cash
222,220
258,725
380,874
Stockholders' equity
(815,433)
(744,262)
(809,609)
Invested Capital
3,718,861
3,613,781
3,265,684
ROIC
14.53%
15.19%
17.95%
ROCE
20.74%
19.67%
22.07%
EV
Common stock shares outstanding
284,906
283,222
280,096
Price
13.68
-18.81%
16.85
102.28%
8.33
-64.63%
Market cap
3,897,514
-18.33%
4,772,291
104.54%
2,333,200
-64.54%
EV
6,098,635
6,901,448
3,943,460
EBITDA
765,932
737,496
702,558
EV/EBITDA
7.96
9.36
5.61
Interest
164,691
142,878
80,144
Interest/NOPBT
27.34%
24.76%
14.39%